Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 15/1096 | 84/18670 | 0.0000999 | 0.001266 | 0.0008587 | 15 | RABC84 | |
BP | GO:0048144 | fibroblast proliferation | 15/1096 | 84/18670 | 0.0000999 | 0.001266 | 0.0008587 | 15 | RABC84 | |
BP | GO:0032757 | positive regulation of interleukin-8 production | 11/1096 | 49/18670 | 0.0001004 | 0.001266 | 0.0008587 | 11 | RABC84 | |
BP | GO:1990090 | cellular response to nerve growth factor stimulus | 11/1096 | 49/18670 | 0.0001004 | 0.001266 | 0.0008587 | 11 | RABC84 | |
BP | GO:0030323 | respiratory tube development | 24/1096 | 176/18670 | 0.0001006 | 0.001266 | 0.0008587 | 24 | RABC84 | |
BP | GO:0032273 | positive regulation of protein polymerization | 20/1096 | 134/18670 | 0.0001072 | 0.001343 | 0.0009112 | 20 | RABC84 | |
BP | GO:0046683 | response to organophosphorus | 20/1096 | 134/18670 | 0.0001072 | 0.001343 | 0.0009112 | 20 | RABC84 | |
BP | GO:0019751 | polyol metabolic process | 19/1096 | 124/18670 | 0.0001106 | 0.001384 | 0.0009385 | 19 | RABC84 | |
BP | GO:1901623 | regulation of lymphocyte chemotaxis | 8/1096 | 27/18670 | 0.0001119 | 0.001397 | 0.0009473 | 8 | RABC84 | |
BP | GO:0035306 | positive regulation of dephosphorylation | 12/1096 | 58/18670 | 0.0001139 | 0.001419 | 0.0009624 | 12 | RABC84 | |
BP | GO:0045185 | maintenance of protein location | 17/1096 | 105/18670 | 0.0001257 | 0.001561 | 0.001059 | 17 | RABC84 | |
BP | GO:0010927 | cellular component assembly involved in morphogenesis | 18/1096 | 115/18670 | 0.0001259 | 0.001561 | 0.001059 | 18 | RABC84 | |
BP | GO:0071347 | cellular response to interleukin-1 | 24/1096 | 179/18670 | 0.0001313 | 0.001619 | 0.001098 | 24 | RABC84 | |
BP | GO:0001776 | leukocyte homeostasis | 15/1096 | 86/18670 | 0.0001317 | 0.001619 | 0.001098 | 15 | RABC84 | |
BP | GO:0032760 | positive regulation of tumor necrosis factor production | 15/1096 | 86/18670 | 0.0001317 | 0.001619 | 0.001098 | 15 | RABC84 | |
BP | GO:0070542 | response to fatty acid | 15/1096 | 86/18670 | 0.0001317 | 0.001619 | 0.001098 | 15 | RABC84 | |
BP | GO:0072010 | glomerular epithelium development | 7/1096 | 21/18670 | 0.0001323 | 0.001622 | 0.0011 | 7 | RABC84 | |
BP | GO:0006959 | humoral immune response | 39/1096 | 356/18670 | 0.0001329 | 0.001627 | 0.001103 | 39 | RABC84 | |
BP | GO:2000351 | regulation of endothelial cell apoptotic process | 12/1096 | 59/18670 | 0.0001355 | 0.001655 | 0.001122 | 12 | RABC84 | |
BP | GO:0097327 | response to antineoplastic agent | 16/1096 | 96/18670 | 0.0001389 | 0.001692 | 0.001148 | 16 | RABC84 | |
BP | GO:0051480 | regulation of cytosolic calcium ion concentration | 39/1096 | 357/18670 | 0.000141 | 0.001715 | 0.001163 | 39 | RABC84 | |
BP | GO:0002456 | T cell mediated immunity | 17/1096 | 106/18670 | 0.0001417 | 0.001719 | 0.001166 | 17 | RABC84 | |
BP | GO:0007254 | JNK cascade | 27/1096 | 214/18670 | 0.0001459 | 0.001766 | 0.001198 | 27 | RABC84 | |
BP | GO:0060048 | cardiac muscle contraction | 20/1096 | 137/18670 | 0.0001462 | 0.001766 | 0.001198 | 20 | RABC84 | |
BP | GO:0045926 | negative regulation of growth | 30/1096 | 249/18670 | 0.0001485 | 0.001791 | 0.001215 | 30 | RABC84 | |
BP | GO:0010863 | positive regulation of phospholipase C activity | 10/1096 | 43/18670 | 0.0001511 | 0.001818 | 0.001233 | 10 | RABC84 | |
BP | GO:1901222 | regulation of NIK/NF-kappaB signaling | 18/1096 | 117/18670 | 0.0001576 | 0.001892 | 0.001284 | 18 | RABC84 | |
BP | GO:0042113 | B cell activation | 35/1096 | 310/18670 | 0.0001609 | 0.001927 | 0.001307 | 35 | RABC84 | |
BP | GO:0046631 | alpha-beta T cell activation | 20/1096 | 138/18670 | 0.0001617 | 0.001933 | 0.001311 | 20 | RABC84 | |
BP | GO:0014074 | response to purine-containing compound | 21/1096 | 149/18670 | 0.0001675 | 0.001994 | 0.001352 | 21 | RABC84 |